Technical Analysis for AVGR - Avinger, Inc.

Grade Last Price % Change Price Change
grade D 1.262 -1.41% -0.02
AVGR closed up 25.49 percent on Tuesday, November 19, 2019, on 2.14 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical AVGR trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -1.41%
Crossed Above 50 DMA Bullish -1.41%
New Uptrend Bullish -1.41%
Expansion Pivot Buy Setup Bullish Swing Setup -1.41%
Pocket Pivot Bullish Swing Setup -1.41%
Wide Range Bar Range Expansion -1.41%
Wide Bands Range Expansion -1.41%
Up 3 Days in a Row Strength -1.41%
Oversold Stochastic Weakness -1.41%
50 DMA Resistance Bearish 23.73%

Older signals for AVGR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Avinger, Inc., a medical device company, designs, manufactures, and sells image-guided, catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD). It offers Lightbox, an imaging console, which enables the use of lumivascular catheters during PAD procedures; Ocelot, a chronic total occlusion (CTO) crossing catheter, which allows physicians to see the inside of an artery during a CTO crossing procedure; Ocelot PIXL, a lower profile CTO-crossing device for below-the-knee arteries; and Ocelot MVRX, a device which offers a tip design for above-the-knee arteries. The company also provides Wildcat, a catheter that facilitates the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention; and Kittycat 2, a catheter that facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists directly in the United States and Europe. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Medicine Medical Specialties Clinical Medicine Imaging Catheters Medical Imaging Catheter Interventional Radiology Interventional Cardiology Cordis Peripheral Arterial Disease Percutaneous
Is AVGR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 12.6
52 Week Low 0.77
Average Volume 563,326
200-Day Moving Average 3.7542
50-Day Moving Average 1.0312
20-Day Moving Average 1.1637
10-Day Moving Average 1.0439
Average True Range 0.142
ADX 26.59
+DI 32.9085
-DI 20.7687
Chandelier Exit (Long, 3 ATRs ) 1.124
Chandelier Exit (Short, 3 ATRs ) 1.2911
Upper Bollinger Band 1.5031
Lower Bollinger Band 0.8243
Percent B (%b) 0.67
BandWidth 58.331185
MACD Line -0.0051
MACD Signal Line 0.0067
MACD Histogram -0.0117
Fundamentals Value
Market Cap 30.6 Million
Num Shares 23.9 Million
EPS -2.46
Price-to-Earnings (P/E) Ratio -0.52
Price-to-Sales 0.50
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.76
Resistance 3 (R3) 1.72 1.52 1.68
Resistance 2 (R2) 1.52 1.40 1.54 1.65
Resistance 1 (R1) 1.40 1.32 1.46 1.44 1.63
Pivot Point 1.20 1.20 1.23 1.22 1.20
Support 1 (S1) 1.08 1.08 1.14 1.12 0.93
Support 2 (S2) 0.88 1.00 0.90 0.91
Support 3 (S3) 0.76 0.88 0.88
Support 4 (S4) 0.80